Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Blue chip cryptos offer resilience, liquidity, and potential for steady growth. Learn the main reasons to consider them as a foundational holding.
19,368 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Former first lady Michelle Obama offers a fresh take on her Go High motto, portraying it as a guardrail for disciplin...
Cogent’s Q4 2025 results show steady growth with improving margins and cautious guidance for 2026. This article inter...
A growing number of retirees are using the 62-to-70 Roth conversion window to move sizeable balances into Roth accoun...
Bitcoin stays near $67K as a rising Power Law floor tightens the squeeze on the price, setting up a potential shift b...
Pi Network’s PI token rebounded to the $0.13 level as buying returns, setting up a critical test of resistance this w...
Tesla is ending production of its flagship Model S and Model X. This article breaks down the real reasons behind the ...
Planet Labs sinks 10% in early trading as traders rotate capital toward SpaceX-linked opportunities, signaling a sect...
A private defense contractor is pushing the Navy toward autonomous, unmanned surface ships. This article explains the...
AST SpaceMobile has been one of the most volatile names in the space economy. After a dramatic rally, the stock pulle...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
Retirees face a shifting rate landscape. This guide explains how a possible 2026 rate rise could affect income, withd...